Answer:
The right answer is D.
Explanation:
The messenger ribonucleic acid, messenger RNA, or mRNA is a transient copy of a portion of the DNA corresponding to one or more genes. mRNA is used as an intermediate by cells for protein synthesis. Jacques Monod, François Jacob, and their collaborators issued and showed the concept of messenger RNA in 1960.
Answer:
Thrombocytes. Thrombocytes (platelets) play an important role in hemostasis, by plugging and repairing damaged blood vessels, thus preventing blood loss. They also participate in a cascade of events that leads to blood clotting by triggering the release of a series of coagulation factors
An abnormal cycle during the cell cycle will be that Cytokinesis partially splits a cell into two, resulting in a cell with two nuclei.
When the cells become non-responsive to chemicals that control their growth, the cell cycle is disrupted and this then leads to the <em>cells</em> division uncontrollably which then leads to a disease that's called cancer.
Disruption to the cell cycle is dangerous to an organism because it can result in the production of abnormal or nonfunctional <em>cells</em>.
It should be noted that in a situation where the cells fail to recognize the chemicals that regulate the cell cycle, the <em>cell cycle</em> could become disrupted.
In conclusion, the regulation of the cell cycle is vital to the survival of <em>organisms</em> as it helps to control cell growth and division.
Read related link on:
brainly.com/question/17810370
The answer is commensalism.
<span>Commensalism is a relationship between two organisms in which only
one of them has benefit, and the other one is not affected. In this example, the Great Burdock's plants spread their seeds using animals, so they benefit from this relationship. On the other hand, animals neither have benefits not are harmed from the relationship.
Therefore, the relationship between </span><span>the Great Burdock plants and animals is the example of commensalism.</span>
Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
